��������

Craig Asher is the Managing Director at OMX Ventures, a committed capital fund investing in bio tools and therapeutics startups at the intersection of data/engineering and biology. Prior to OMX Ventures, Craig was the Managing Partner at Trancos Ventures and Principal at Vital Venture Capital LLC. Craig also serves on the boards of VedaBio and Glyphic Biotechnologies, and as a Board Observer for Constructive Bio and Aperiam Bio. Additionally, Craig is an investor in Replay and a Board Observer for Lightcast Discovery. Craig is a member of Business Executives for National Security (BENS) and holds degrees from Northwestern University, Stanford University, and Heidelberg University.